Cell Press Reviews: Cancer Therapeutics provides an overview of key recent advances and open research questions in cancer treatment. With articles written by leading researchers in the field, this publication offers the most up-to-date insights into how genetics influences treatment decisions and how the immune system can be employed to battle cancer, and describes the current state of the art in drug discovery and targeted treatments. Contributors to this compilation include many prominent researchers in the field, such as: Daniel A. Haber, Director, Massachusetts General Hospital Cancer Center; Professor, Harvard Medical School; Tony Kouzarides, Professor, University of Cambridge; Deputy Director, Wellcome Trust/Cancer Research UK Gurdon Institute; founder, Chroma Therapeutics; and Charles L. Sawyers, Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center; President, American Association for Cancer Research; member, National Cancer Advisory Board; recipient, 2013 Breakthrough Prize in Life Sciences. Cell Press Reviews: Cancer Therapeutics will assist both experts and those new to the field in understanding the current state and future direction of cancer therapy. This publication is part of the Cell Press Reviews series, which brings together topical review articles recently published in Cell Press journals, including the Trends in. series. These compilations are curated by Cell Press journal editors and offer comprehensive updates from leaders in the field on the most cutting-edge and important scientific questions. It provides timely, comprehensive articles on a wide range of topics in cancer therapeutics. It offers insight from experts on genetic, molecular, and cellular aspects of cancer therapy. It features reviews on basic science advances translated into drug discovery and therapeutic approaches. It includes articles originally published in Cell, Cancer Cell, Trends in Genetics, Trends in Molecular Medicine, and Trends in Pharmacological Sciences.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publicatio offers a broad view of some of the most compelling topics in cancer therapeutics including:
Contributions come from leading voices in the field, including: - Daniel A. Haber, Director of Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School - Tony Kouzarides, Professor at the University of Cambridge, Deputy Director of the Wellcome Trust/Cancer Research UK Gurdon Institute, and a founder of the cancer drug discovery company Chroma Therapeutics - Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, President of the American Association for Cancer Research, member of the presidentially appointed National Cancer Advisory Board, and recipient of the 2013 Breakthrough Prize in Life Sciences
Cell Press Reviews: Cancer Therapeutics is part of the Cell Press Reviews series, which features reviews published in Cell Press primary research and Trends reviews journals.
"...offers the most up-to-date insights into how genetics influences treatnent decisions and how the immune system can be employed to battle cancer, and describes the current state-of-the-art in drug discovery and targeted treatments." --Anticancer Research, January 2015
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur 9a7229ac238b438edda1f992167d1c4f
Quantité disponible : Plus de 20 disponibles
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. pp. 322. N° de réf. du vendeur 96130751
Quantité disponible : 3 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 1st edition. 322 pages. 9.25x7.50x0.50 inches. In Stock. N° de réf. du vendeur __012420192X
Quantité disponible : 2 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. pp. 322. N° de réf. du vendeur 1897347946
Quantité disponible : 3 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. pp. 322. N° de réf. du vendeur 2697347936
Quantité disponible : 3 disponible(s)
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Paperback / softback. Etat : New. New copy - Usually dispatched within 4 working days. N° de réf. du vendeur B9780124201927
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publicatio offers a broad view of some of the most compelling topics in cancer therapeutics including: Genetic approaches for personal oncology Targeting epigenetic dysregulation and protein interaction networks Vaccines and antibodies in cancer immunotherapy Tumor heterogeneity and chemotherapy resistance Tumor associated macrophages in anticancer treatment Contributions come from leading voices in the field, including:- Daniel A. Haber, Director of Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School- Tony Kouzarides, Professor at the University of Cambridge, Deputy Director of the Wellcome Trust/Cancer Research UK Gurdon Institute, and a founder of the cancer drug discovery company Chroma Therapeutics- Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, President of the American Association for Cancer Research, member of the presidentially appointed National Cancer Advisory Board, and recipient of the 2013 Breakthrough Prize in Life Sciences Cell Press Reviews: Cancer Therapeutics is part of the Cell Press Reviews series, which features reviews published in Cell Press primary research and Trends reviews journals. 322 pp. Englisch. N° de réf. du vendeur 9780124201927
Quantité disponible : 2 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Cell Press Reviews: Cancer Therapeutics | Cell Press | Taschenbuch | Englisch | 2013 | Elsevier Science | EAN 9780124201927 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu. N° de réf. du vendeur 105547872
Quantité disponible : 5 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publicatio offers a broad view of some of the most compelling topics in cancer therapeutics including: Genetic approaches for personal oncology Targeting epigenetic dysregulation and protein interaction networks Vaccines and antibodies in cancer immunotherapy Tumor heterogeneity and chemotherapy resistance Tumor associated macrophages in anticancer treatment Contributions come from leading voices in the field, including:- Daniel A. Haber, Director of Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School- Tony Kouzarides, Professor at the University of Cambridge, Deputy Director of the Wellcome Trust/Cancer Research UK Gurdon Institute, and a founder of the cancer drug discovery company Chroma Therapeutics- Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, President of the American Association for Cancer Research, member of the presidentially appointed National Cancer Advisory Board, and recipient of the 2013 Breakthrough Prize in Life Sciences Cell Press Reviews: Cancer Therapeutics is part of the Cell Press Reviews series, which features reviews published in Cell Press primary research and Trends reviews journals. N° de réf. du vendeur 9780124201927
Quantité disponible : 2 disponible(s)